Navigation Links
Shire plc: IFRS Results for the Year Ending December 31, 2007
Date:3/25/2008

BASINGSTOKE, England, March 25 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces its preliminary results prepared under International Financial Reporting Standards ("IFRS") for the twelve months to December 31, 2007.

On February 21, 2008 Shire announced its results for the same period under US GAAP.

Notes to Editors

Shire plc

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com

The "Safe Harbor" Statement Under The Private Securities Litigation Reform Act of 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialise, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research; product development including, but not limited to, the successful development of JUVISTA(R) (Human TGFbeta3) and velaglucerase alfa (G
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
2. Shire plc: Correction Re Website
3. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
4. Shire Engages Palio
5. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
6. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
7. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
8. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
9. Shire plc: Board Changes
10. David Mott Appointed Non Executive Director at Shire
11. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2008)... -- Company Maintains Full Year Guidance, S...ll/ -- Mindray,Medical International Limited (NYSE...keter of medical devices worldwide today announced...second quarter ended June 30, 2008.,During the qua...on of,Datascope Corp.,s patient monitoring busines...
(Date:9/3/2008)...ed Industry Executive to Lead Company,s Business D...s, BEDFORD, Mass., Sept. 3 /PRNewswire-FirstCall/...er in patch pump technology with its OmniPod(R),In...ntment of William,"Bill" D. Arthur III as Vice Pre...Arthur will lead the company,s business developmen...
(Date:9/3/2008)...press RP-Amide provides improved selectivity for p...rstCall/ -- Supelco, a division of,Sigma-Aldrich (... product,line ( http://www.sigma-aldrich.com/expre... to provide the analysis speed and resolving power...ackpressure. Ascentis Express,RP-Amide, an embedde...
(Date:9/3/2008)...earnal appointed Senior Vice President, Commercial...re/ -- Cumberland Pharmaceuticals,Inc. has appoint...ce,President, Commercial Development. In this newl...volved with Cumberland,s commercial strategy and,b.../www.newscom.com/cgi-bin/prnh/20080903/CLW115 ), ...
Breaking Biology Technology:Mindray Medical International Announces Second Quarter 2008 Results 2Mindray Medical International Announces Second Quarter 2008 Results 3Mindray Medical International Announces Second Quarter 2008 Results 4Mindray Medical International Announces Second Quarter 2008 Results 5Mindray Medical International Announces Second Quarter 2008 Results 6Mindray Medical International Announces Second Quarter 2008 Results 7Mindray Medical International Announces Second Quarter 2008 Results 8Mindray Medical International Announces Second Quarter 2008 Results 9Mindray Medical International Announces Second Quarter 2008 Results 10Mindray Medical International Announces Second Quarter 2008 Results 11Mindray Medical International Announces Second Quarter 2008 Results 12Mindray Medical International Announces Second Quarter 2008 Results 13Mindray Medical International Announces Second Quarter 2008 Results 14Mindray Medical International Announces Second Quarter 2008 Results 15Mindray Medical International Announces Second Quarter 2008 Results 16Mindray Medical International Announces Second Quarter 2008 Results 17Insulet Appoints Bill Arthur as Vice President of Business Development 2Insulet Appoints Bill Arthur as Vice President of Business Development 3Insulet Appoints Bill Arthur as Vice President of Business Development 4Supelco(R) Expands Ascentis(R) Express HPLC Columns Line for High-Speed and High-Efficiency Separations 2Cumberland Pharmaceuticals Taps Industry Veteran for Key Executive Position 2
... stories to tell, but perhaps nothing is more illu...ory of a little girl drawing in the back of a clas...ul Getty Trust in Los Angeles and an internationa..., told the story during a keynote address at the a...Association Conference. , ,Noting that young chil...
...ago Bar Association entitled "Communication Rights...t Century." At that time, many who attended thou...faith in it. My argument was that the horse-and-bu...d liquor were maxed out. Municipalities would have...ms that could pay for services and pensions. , ,Th...
...n Internet data provider, has appointed its legal ...ions officer. , ,Meier brings experience in the le...and he will be responsible for helping the Milwauk...and business development programs. , ,"I believe i...go when it was just two people and an idea," Donat...
...and his company through a series of mergers and pe...der of JT Packard & Associates, Inc. , Cason pres...er. The company has grown by 500 percent over the ...ptible power supply (UPS) service company in the c...,With its recent purchase by Anaheim, Calif.-based...
Other Biology Technology:Sir Ken Robinson: Companies, kids "get" innovation, but K-12 doesn't nurture it 2Sir Ken Robinson: Companies, kids "get" innovation, but K-12 doesn't nurture it 3Creativity, innovation extend to municipalities 2Creativity, innovation extend to municipalities 3Creativity, innovation extend to municipalities 4Power services firm JT Packard isn't through growing 2Power services firm JT Packard isn't through growing 3
(Date:9/4/2008)...Sept. 4, 2008 As the anniversary of the September...ety (ACS) has issued a new podcast describing an a...y and national security. The podcast is the sixth...mistry Solutions )series. , With new episodes po...nting problems facing society in the 21st Century,...
(Date:9/4/2008)...Ala. -- A team including researchers at the Hudson...with colleagues from a number of other organizatio...nomic variation in the brain cancer glioblastoma. ... Atlas (TCGA) research network, a collaborative ef...he National Human Genome Research Institute of the...
(Date:9/4/2008)...searchers and a pathology company have joined forc...hich may reveal a way to predict premature birth w...e, the University of Newcastle and Symbion Patholo...ngineering and pathology to develop a computer pro...h., About 17,000 pre-term births occur in Austral...
(Date:9/4/2008)...ell research is the next great leap in medicine. I...ld replace a failing heart, or new cells take the ...sing stem cells from embryonic sources, which open...ues, scientists have been looking to adult human s...stem cells are now being cultivated from various t...
Breaking Biology News(10 mins):New 'chemical radar' among national security innovations in ACS podcast 2New 'chemical radar' among national security innovations in ACS podcast 3Collaboration between researchers yields more comprehensive portrait of brain cancer 2World-first to predict premature births 2Tel Aviv University researchers create new stem cell screening tool 2New research demonstrates potential diagnosis treatment benefits 9374 1New research demonstrates potential diagnosis treatment benefits 9374 2New research demonstrates potential diagnosis treatment benefits 9374 3New research demonstrates potential diagnosis treatment benefits 9374 4Stanford researchers publish review of US medical device regulation 1841 1Stanford researchers publish review of US medical device regulation 1841 2Stanford researchers publish review of US medical device regulation 1841 3New computed tomography system marketed 9373 1New computed tomography system marketed 9373 2Simple test accurately predicts risk of serious jaundice in newborns 9371 1Simple test accurately predicts risk of serious jaundice in newborns 9371 2
...he Montreal Summit on global climate being held th...ns, by a University of California, Santa Barbara s... issue of the journal Geology, underlines concern ...pical ocean temperatures and land vegetation have ...plains first author Syee Weldeab, a post-doctoral ...
...ll, farmers are cultivating more and more land in ...fying needs of humans. , As a result, agricultural...arth,s landscape and has emerged as one of the cen...ientists at the Center for Sustainability and the ...consin-Madison. , Navin Ramankutty, an assistant...
...top to ogle the country,s many saltwater lagoons, ..., too, admire these saltern crystallizers--and eve...such briny environs. Now, reporting in the Novembe...dings of the National Academy of Sciences, researc...laborators reveal the genome of one bacterium at h...
... strategy to treat tumors by selectively targeting...l study, published in the open access journal PLoS...blastoma multiforme (GBM). This is the most aggres...fore symptoms are experienced and killing most pat...ce, Alexander Levitzki and colleagues (of The Hebr...
Other Biology News:Tropical Atlantic cooling and African deforestation correlate to drought, report scientists 2New maps reveal true extent of human footprint on Earth 2A salty tale: New bacterial genome sequenced from ancient salterns 2Preclinical study of a new brain tumor therapy 2
Aldolase A (N-15)
Bovine Renal Artery Endothelial Cells (BRAEC) (>500,000 cells)
...tor antiserum This NPY Y2 antibody has been exte...urrently being characerized in brain. The antibody... to work better on mose tissue, although positive ... in dorsal root ganglion and spinal cord see: J Co...
RECK (F-20)
Biology Products: